Boundless Bio, Inc. (BOLD)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Zachary Hornby | CEO, President & Director | 879.59k | -- | 1979 |
| Dr. Christian Hassig Ph.D. | Chief Scientific Officer | 614.84k | -- | 1972 |
| Mr. David Hinkle | Senior VP of Finance, Controller & Corporate Treasurer | -- | -- | 1962 |
| Ms. Jessica Oien J.D. | Chief Legal Officer & Corporate Secretary | -- | -- | 1971 |
| Mr. Anthony Pinkerton Ph.D. | Senior Vice President of Drug Discovery | -- | -- | -- |
| Ms. Meredith Wesley | Senior Vice President of Talent & Culture | -- | -- | -- |
| Dr. Peter Krein Ph.D. | Senior Vice President of Precision Medicine | -- | -- | -- |
| Ms. Amy Berkley Ph.D. | Senior Vice President of Program Team | -- | -- | -- |
| Ms. Sara Weymer | Senior Vice President of Clinical Operations | -- | -- | -- |
| Dr. James L. Freddo M.D. | Interim Chief Medical Officer | -- | -- | 1955 |
Boundless Bio, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 64
Description
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
April 8, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission